The momentum created during the COVID-19 pandemic has highlighted the importance of
speedy, high-quality, scalable, reliable, and affordable vaccine manufacturing, as means to …

Among the most pressing issues in preparing for the global response to a pandemic are the
design, development, manufacture, and dissemination of vaccines. In 2018 and 2019, we …

The development of vaccines for COVID-19 occurred at an unprecedented pace, and 32
vaccines using a broad range of technologies had received authorization for use on an …

The coronavirus disease 2019 (COVID-19) pandemic has prompted rapid investigation and
deployment of vaccine platforms never before used to combat human disease. The severe …

Industry partnerships for platform technologies (technologies used as a base on which other
applications, processes, or technologies are developed) forged during the COVID-19 …

The global reach of infectious disease pandemics typically necessitates a similarly
ubiquitous public health intervention: mass vaccination. The development and large-scale …

While the world continues to respond to the COVID-19 pandemic, novel influenza viruses
persist as a constant pandemic threat. The global response to COVID-19 has pushed the …

In the race for global equity of Covid-19 vaccines, there are several critical interconnected
pillars, including vaccine research and development; purchases; manufacturing; distribution; …

This paper reviews the recommendations, gaps in implementation, and subsequent
guidance on sustainable incorporation of these recommendations in the future from previous …

This chapter addresses the first of the four dimensions of vaccine research, development,
and manufacturing examined by the committee. Key findings about vaccine research and …